Advancing Laboratory Diagnostics for Future Pandemics: Challenges and Innovations
Open Access
Abstract
Since the beginning of the 21st century, major epidemics and pandemics such as SARS, H1N1pdm09, Ebola, and COVID-19 have repeatedly challenged global systems of disease diagnostics and control. These crises exposed the weaknesses of traditional diagnostic models, including long turnaround times, uneven resource distribution, and supply chain bottlenecks. As a result, there is an urgent need for more advanced diagnostic technologies and integrated diagnostics strategies. Our review summarizes key lessons learned from four recent major outbreaks and highlights advances in diagnostic technologies. Among these, molecular techniques such as loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), recombinase polymerase amplification (RPA), and droplet digital polymerase chain reaction (ddPCR) have demonstrated significant advantages and are increasingly becoming core components of the detection framework. Antigen testing plays a critical role in rapid screening, particularly in settings such as schools, workplaces, and communities. Serological assays provide unique value for retrospective outbreak analysis and assessing population immunity. Next-generation sequencing (NGS) has become a powerful tool for identifying novel pathogens and monitoring viral mutations. Furthermore, point-of-care testing (POCT), enhanced by miniaturization, biosensing, and artificial intelligence (AI), has extended diagnostic capacity to the front lines of epidemic control. In summary, the future of epidemic and pandemic response will not depend on a single technology, but rather on a multi-layered and complementary system. By combining laboratory diagnostics, distributed screening, and real-time monitoring, this system will form a global diagnostic network capable of rapid response, ensuring preparedness for the next global health crisis.Keywords
This publication has 92 references indexed in Scilit:
- Isothermal nucleic acid amplification and its uses in modern diagnostic technologies3 Biotech, 2023
- Viral epidemic preparedness: a perspective from five clinical microbiology laboratories in EuropeClinical Microbiology and Infection, 2023
- Strategies for Scaling up SARS-CoV-2 Molecular Testing CapacityClinics In Laboratory Medicine, 2022
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future InfectionJAMA Internal Medicine, 2021
- Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimensAnalytical and Bioanalytical Chemistry, 2021
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- Next-Generation Sequencing of Infectious PathogensJAMA, 2019
- Severe Respiratory Viral InfectionsInfectious Disease Clinics of North America, 2017
- Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well platesJournal of Virological Methods, 1991